|
YES1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.48149999999758E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.88519999999781E-05 |
| Normal-vs-Stage2 |
1.317030E-03 |
| Normal-vs-Stage3 |
1.147630E-02 |
| Normal-vs-Stage4 |
9.291500E-02 |
| Stage1-vs-Stage2 |
8.164200E-01 |
| Stage1-vs-Stage3 |
8.595000E-01 |
| Stage1-vs-Stage4 |
8.842800E-01 |
| Stage2-vs-Stage3 |
7.432800E-01 |
| Stage2-vs-Stage4 |
9.842000E-01 |
| Stage3-vs-Stage4 |
8.294400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.18019999999442E-05 |
| Normal-vs-AfricanAmerican |
3.438000E-04 |
| Normal-vs-Asian |
4.775800E-03 |
| Caucasian-vs-AfricanAmerican |
8.767800E-01 |
| Caucasian-vs-Asian |
5.104000E-01 |
| AfricanAmerican-vs-Asian |
4.885600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.75999999999055E-06 |
| Normal-vs-Female |
7.620400E-02 |
| Male-vs-Female |
1.101730E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.158700E-03 |
| Normal-vs-Extreme_Weight |
7.28099999958154E-07 |
| Normal-vs-Obese |
2.040700E-04 |
| Normal-vs-Extreme_Obese |
3.249600E-01 |
| Normal_Weight-vs-Extreme_Weight |
1.415400E-01 |
| Normal_Weight-vs-Obese |
8.131800E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.894400E-01 |
| Extreme_Weight-vs-Obese |
9.746100E-02 |
| Extreme_Weight-vs-Extreme_Obese |
2.905200E-01 |
| Obese-vs-Extreme_Obese |
5.162600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.518000E-02 |
| Normal-vs-Age(41-60Yrs) |
1.417810E-03 |
| Normal-vs-Age(61-80Yrs) |
1.70622999999814E-05 |
| Normal-vs-Age(81-100Yrs) |
8.582000E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.915000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.148200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.914790E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.283200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.326200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.006600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.97272999999942E-05 |
| Normal-VS-Type2 PRCC |
5.025700E-04 |
| Normal-VS-KIRP CIMP |
8.730600E-01 |
| Normal-VS-Unclassified PRCC |
3.727600E-02 |
| Type1 PRCC-VS-Type2 PRCC |
9.728000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
4.940100E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
6.575000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.039580E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
6.611600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.137580E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.59369999991932E-07 |
| Normal-vs-N1 |
1.993180E-01 |
| Normal-vs-N2 |
2.739700E-02 |
| N0-vs-N1 |
1.152030E-02 |
| N0-vs-N2 |
9.105600E-01 |
| N1-vs-N2 |
3.100800E-01 |
|
|
